These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8020013)

  • 21. Myocardial ischemia: current concepts and future perspectives.
    Shimokawa H; Yasuda S
    J Cardiol; 2008 Oct; 52(2):67-78. PubMed ID: 18922380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy.
    Shaw J; Anderson T
    Vasc Med; 2016 Apr; 21(2):146-55. PubMed ID: 26675331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac syndrome X: a critical overview and future perspectives.
    Lanza GA
    Heart; 2007 Feb; 93(2):159-66. PubMed ID: 16399854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ischemia with normal coronary arteries: a puzzle and an opportunity.
    Tritto I; Conti MG; Ambrosio G
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):309-10. PubMed ID: 21451332
    [No Abstract]   [Full Text] [Related]  

  • 25. Low Incidence of Diabetes Mellitus in Coronary Microvascular Dysfunction: An Intriguing Association.
    Chhabra L; Kowlgi NG
    JACC Cardiovasc Interv; 2016 Feb; 9(4):395-396. PubMed ID: 26777324
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply: Low Incidence of Diabetes Mellitus in Coronary Microvascular Dysfunction: An Intriguing Association.
    Sara JD; Lerman A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):396. PubMed ID: 26892090
    [No Abstract]   [Full Text] [Related]  

  • 27. [A case of stable microvascular angina with normal coronary arteries: certainties and doubts].
    Coppola A
    Clin Ter; 2015; 166(1):26-31. PubMed ID: 25756257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can Advanced Physiological Testing Bridge the Gap Between Chest Pain and Nonobstructive Coronary Atherosclerosis?
    Yoo SY; Samady H
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1454-1456. PubMed ID: 26404198
    [No Abstract]   [Full Text] [Related]  

  • 29. Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement.
    Lozano I; Rondan J; Vegas JM; Segovia E
    JACC Cardiovasc Interv; 2016 Feb; 9(4):392-393. PubMed ID: 26777333
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply: Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement.
    Yoo B; Samady H
    JACC Cardiovasc Interv; 2016 Feb; 9(4):393-394. PubMed ID: 26892087
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vasodilative characteristics of coronary microcirculation in patients of syndrome X].
    Mikuniya A; Fujino Y; Hanada H; Onodera K
    Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):423-8. PubMed ID: 12440006
    [No Abstract]   [Full Text] [Related]  

  • 32. Reply: Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement.
    Sara JD; Lerman A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):393. PubMed ID: 26892088
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial ischemia and the pains of the heart.
    Panza JA
    N Engl J Med; 2002 Jun; 346(25):1934-5. PubMed ID: 12075053
    [No Abstract]   [Full Text] [Related]  

  • 34. Coronary microvascular dysfunction in patients with cardiac syndrome X: Ongoing debate.
    Celik T; Ozturk C; Balta S; Demirkol S; Iyisoy A
    Int J Cardiol; 2016 Sep; 218():233-234. PubMed ID: 27236120
    [No Abstract]   [Full Text] [Related]  

  • 35. [Microvascular angina].
    Katagiri T; Suzuki H; Takeyama Y
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():223-7. PubMed ID: 17948704
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiovascular syndrome X and endothelial dysfunction].
    Vázquez-Rey E; Kaski JC
    Rev Esp Cardiol; 2003 Feb; 56(2):181-92. PubMed ID: 12605764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is NPY causing myocardial ischemia in patients with microvascular angina associated with its abnormal constrictor response at the microcirculation level?
    Zhao Y; Qin F; He B; Liu X
    Int J Cardiol; 2017 Nov; 247():52. PubMed ID: 28916089
    [No Abstract]   [Full Text] [Related]  

  • 38. The pathophysiology and clinical course of the normal coronary angina syndrome (cardiac syndrome X).
    Melikian N; De Bruyne B; Fearon WF; MacCarthy PA
    Prog Cardiovasc Dis; 2008; 50(4):294-310. PubMed ID: 18156008
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacotherapy for coronary microvascular dysfunction.
    Ong P; Athanasiadis A; Sechtem U
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):65-71. PubMed ID: 27533969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into the pathophysiology, classification, and diagnosis of coronary microvascular dysfunction.
    Ahmed B
    Coron Artery Dis; 2014 Aug; 25(5):439-49. PubMed ID: 24818640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.